Urogen Pharma Ltd. (URGN)
NASDAQ · Healthcare
Urogen Pharma Ltd. Shareholder Equity 2016–2025
Urogen Pharma Ltd. annual shareholder equity history from 2017 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Urogen Pharma Ltd. shareholder equity as of December 31, 2025: -105.5M, a 1098.16% increase year-over-year.
- Urogen Pharma Ltd. shareholder equity for 2025 were -105.5M, a 1098.16% increase from 2024.
- Urogen Pharma Ltd. shareholder equity for 2024 were -8.8M, a 86.50% decrease from 2023.
- Urogen Pharma Ltd. shareholder equity for 2023 were -65.2M, a 27.02% decrease from 2022.
- Urogen Pharma Ltd. shareholder equity for 2022 were -89.4M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Urogen Pharma Ltd. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-105 |
| 2024 | $-9 |
| 2023 | $-65 |
| 2022 | $-89 |
| 2021 | $8 |
| 2020 | $96 |
| 2019 | $180 |
| 2018 | $90 |
| 2017 | $69 |
Urogen Pharma Ltd. Shareholder Equity — FAQ
Urogen Pharma Ltd. (URGN) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see URGN's shareholder equity history?
The chart and table above show Urogen Pharma Ltd.'s shareholder equity by year and by quarter, including the growth rate.